HSBC TUR.WAR.OP.END. MCP/ DE000HG8U5H8 /
9/6/2024 9:35:17 PM | Chg.-0.1900 | Bid9:59:50 PM | Ask9:59:50 PM | Underlying | Strike price | Expiration date | Option type |
---|---|---|---|---|---|---|---|
1.8700EUR | -9.22% | 1.8100 Bid Size: 40,000 |
1.8900 Ask Size: 40,000 |
Microchip Technology... | 54.2863 USD | 12/31/2078 | Call |
GlobeNewswire
8/27
Autonomix Medical, Inc. to Present at H.C. Wainwright 26th Annual Global Investment Conference
GlobeNewswire
8/21
Autonomix Medical, Inc. Announces Abstract Accepted for Podium Presentation at the 2024 CIRSE Annual...
GlobeNewswire
8/19
Expanded Single Pair Ethernet Portfolio with 100BASE-T1 and 1000BASE-T1 PHY Transceivers for Network...
GlobeNewswire
8/15
Microchip Technology Adds ECC20x and SHA10x Families of Secure Authentication ICs to TrustFLEX Platf...
GlobeNewswire
8/13
Autonomix Medical, Inc. Reports First Quarter Fiscal Year 2025 Financial Results and Reiterates Near...
GlobeNewswire
8/13
Microchip and Acacia Collaborate to Enable Optimized Terabit-Scale Data Center Interconnect Systems
GlobeNewswire
8/3
Microchip Technology to Present at the KeyBanc Capital Markets Technology Leadership Forum
GlobeNewswire
8/2
Autonomix Medical, Inc. (NASDAQ: AMIX) Announces Release of the Next CEO Corner Segment
GlobeNewswire
8/1
Microchip Technology Announces Financial Results for First Quarter of Fiscal Year 2025
GlobeNewswire
8/1
Microchip Technology Increases Quarterly Cash Dividend 10.7% Year-Over-Year to 45.4 Cents Per Share
GlobeNewswire
7/30
Microchip Technology Introduces a New Core in the dsPIC® Digital Signal Controller Family to Enhance...
GlobeNewswire
7/22
Autonomix Medical, Inc. (NASDAQ: AMIX) to Participate in the Virtual Investor Closing Bell Series
GlobeNewswire
7/18
SEALSQ Mitigates Geopolitical Risks by Manufacturing Its Next-Generation Semiconductors in Singapore...
GlobeNewswire
7/18
Autonomix Medical, Inc. (NASDAQ: AMIX) Participates in Virtual Investor “What This Means” Segment Co...
GlobeNewswire
7/18
Silo Pharma and Resyca BV Partner on Device and CMC Development for Intranasal PTSD Drug SPC-15
GlobeNewswire
7/15
Autonomix Enters into Definitive Agreement to License Intellectual Property for FDA-Cleared Ablation...